The investment will go toward finishing a Phase 2a clinical trial for an anti-infective to treat chronic infections in people with CF.
Barisic will transition from current role as Chief Financial and Administrative Officer in January 2023
The Cystic Fibrosis Foundation is providing up to $5 million to develop a method to deliver a healthy copy of the CFTR gene into the lung cells of people with CF that is unlikely to trigger an immune system response.
Addressing variability in newborn screening can prevent missed diagnoses and delays in early care intervention.
CEO pledge is part of the Foundation’s ongoing commitment to strengthen the organization and better serve all people with CF